Alphabet's GV Invests $25 Million in Menopause Care Startup Midi Health
By: WE Staff | Thursday, 28 September 2023
Alphabet's venture capital arm, GV, has made a significant investment in Midi Health, a virtual clinic dedicated to menopause care. The $25 million funding round is set to propel Midi Health's expansion efforts, making comprehensive menopause care accessible to more individuals.
Midi Health's unique approach connects patients with medical professionals through virtual visits, offering solutions for menopause-related symptoms, including brain fog, mood changes, and joint pain. Additionally, the platform extends its services to cancer patients grappling with similar symptoms due to treatments.
The investment will facilitate Midi Health's transition from accepting insurance in 13 U.S. states to a nationwide presence, covering all 50 states. This expansion will offer relief to women experiencing menopause symptoms in areas with limited healthcare access.
What sets Midi Health apart is its commitment to delivering holistic care rather than focusing solely on product offerings, marking a distinctive approach in the menopause care sector. GV's decision to back Midi Health aligns with its vision of addressing larger societal challenges, including the emergence of OB/GYN care deserts in regions where restrictive anti-abortion legislation hampers physician practices.
Midi Health's seasoned team, with a deep understanding of the intricacies of menopause care, played a pivotal role in securing the investment. This experience-driven perspective enhances the platform's ability to cater to the unique needs of women undergoing menopause.
The investment by Alphabet's GV reflects the surging interest in menopause-related healthcare solutions and services. The menopause space has garnered attention from both scientific, technology-driven companies and celebrity brands. However, Midi Health stands out by prioritizing care over products, aiming to provide a comprehensive support system for women navigating the challenges of menopause.
As the menopause care sector continues to evolve, Midi Health's approach could offer women across the United States improved access to high-quality care, thereby positively impacting their health and well-being during this critical life stage. Alphabet's GV, known for strategic investments, sees the potential for Midi Health to drive meaningful change in the healthcare landscape for menopausal and post-menopausal women.